COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 14:00, il y a 1 année 7 mois Sterling Organization Acquires Portfolio of Shopping Centers Totaling Almost One Million Square Feet for $180.5 Million Sterling Organization acquires three-property portfolio from SITE Centers worth $180.5 million, enhancing SVAP IV's shopping center portfolio with high-quality assets in prime markets Acquisition Real Estate Investment Sterling Organization Value-add Shopping Centers
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:55, il y a 1 année 7 mois EQS-Adhoc: ZF Europe Finance B.V.: ZF changes forecast for financial year 2024 ZF Europe Finance B.V. adjusts forecast for financial year 2024 due to market decline and reassessment of risks, expecting lower earnings. Sales forecast lowered to EUR 40-42 billion with adjusted EBIT margin of 3-4 percent Forecast Adjustment Sales Forecast Market Decline ZF Europe Finance B.V. Earnings Expectations
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:55, il y a 1 année 7 mois EQS-Adhoc: ZF Finance GmbH: ZF changes forecast for financial year 2024 ZF Finance GmbH adjusts forecast for financial year 2024 due to weak economy and market decline, lowering sales and earnings expectations Forecast Adjustment Financial Year 2024 Market Decline Earnings Expectations ZF Finance GmbH
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:55, il y a 1 année 7 mois EQS-Adhoc: ZF North America Capital Inc.: ZF changes forecast for financial year 2024 ZF North America Capital Inc. adjusts forecast for 2024 due to market decline and lower earnings expectations, expecting Group sales EUR 40-42 billion, EBIT margin 3-4%, and free cash flow > EUR 100 million Forecast Adjustment Financial Year 2024 Market Decline Earnings Expectations ZF North America Capital Inc.
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:40, il y a 1 année 7 mois United Terra Enterprises PLC Announces Results of Extraordinary Shareholders’ Meeting of Eurybia AG United Terra Enterprises PLC announces successful Eurybia AG shareholders' meeting with approvals for auditors, capital increase, and Articles updates Capital Increase Shareholders' Meeting United Terra Enterprises PLC Eurybia AG Articles Update
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:30, il y a 1 année 7 mois MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 MIRA Pharmaceuticals presents preclinical results at Pain Therapeutics Summit showcasing that Ketamir-2 achieves 100% reversal of neuropathic pain. The innovative therapy targets NMDA receptors for enhanced efficacy Preclinical Results MIRA Pharmaceuticals Ketamir-2 NMDA Receptor Neuropathic Pain
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:29, il y a 1 année 7 mois Changes in the Executive Board of Schaeffler AG Schaeffler AG announces changes in the Executive Board, with new appointments and roles effective from October 1, 2024, to align the company for the upcoming merger with Vitesco Technologies AG Appointments Executive Board Schaeffler AG Financial Officer E-Mobility Division
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:00, il y a 1 année 7 mois Aston Bay and American West Metals Report 22.9m @ 8.5% Cu Intersected at the Storm Project, Nunavut, Canada Drill results show high-grade copper intersections at Storm Project, suggesting expansion potential. NEAS sealift operation saves $4M on 2025 budget High-grade Copper Expansion Potential Storm Project NEAS Sealift 2025 Budget
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:00, il y a 1 année 7 mois Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD Dupixent approved in China as the first-ever biologic medicine for COPD patients, following landmark phase 3 studies. Approval crucial for addressing COPD burden in China China COPD Dupixent Biologic Medicine Phase 3 Studies
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 13:00, il y a 1 année 7 mois Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO, réduit les exacerbations et améliore la fonction respiratoire. Approbation suite à études de phase III Traitement Chine Approbation BPCO Dupixent
Publié le 13/05/2026 à 12:27, il y a 1 heure 47 minutes Franchisee Litigation - The Paris Court of Appeal Rules in Favor of Carrefour
Publié le 13/05/2026 à 12:27, il y a 1 heure 47 minutes Contentieux franchisés : La Cour d’Appel de Paris donne raison à Carrefour
Publié le 13/05/2026 à 11:30, il y a 2 heures 45 minutes Game On for esports jobs: 65% globally demand more education and career pathways for pro gaming
Publié le 13/05/2026 à 10:24, il y a 3 heures 50 minutes Electricité de Strasbourg - Droits de vote au jour de l'avis de réunion de l'AGO du 4 juin 2026
Publié le 13/05/2026 à 10:05, il y a 4 heures 10 minutes Guillemot Corporation S.A. | AGM du 04/06/2026 – Mise à disposition des documents préparatoires
Publié le 13/05/2026 à 14:00, il y a 15 minutes BTU Acquires Property East of Great Bear's World Class Dixie Gold Deposit and Their New Strider Gold Discovery
Publié le 13/05/2026 à 13:00, il y a 1 heure 15 minutes Galway Metals Reports High-Grade Gold Intercepts at Southwest Deposit Including 20.7 g/t Gold over 11.0 Meters
Publié le 13/05/2026 à 08:05, il y a 6 heures 10 minutes Tocvan Announces New Surface Gold-Silver Results, Outlining New Target 3 Kilometers East of Main Zone at Gran Pilar Gold-Silver Project
Publié le 13/05/2026 à 00:00, il y a 14 heures 15 minutes Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Publié le 13/05/2026 à 13:57, il y a 17 minutes Wacker Neuson SE Annual General Meeting approves dividend for the fiscal year 2025
Publié le 13/05/2026 à 13:00, il y a 1 heure 14 minutes Andera Partners Leads $20 Million Series D Financing in Rivermark Medical